Aro Biotherapeutics draws $13M in startup investment to target centyrin proteins


Money currency vector illustration. Various money bills dollar cash paper bank notes and gold coins. Collection of cash heap pile and currency stack vector set.

The company currently has a product candidate in the late-discovery phase, an EGFR-targeting drug for lung cancer that would go after a resistance mechanism against existing kinase inhibitors.


Article Source: Aro Biotherapeutics draws $13M in startup investment to target centyrin proteins.

Post a Comment

0 Comments

InsureZero Blog